CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.

21:33 26/01/2026

China Resources Pharmaceutical (03320) announced that its non-wholly-owned subsidiary, China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane), has received a registration approval notice (CSRC License [2026] No. 118) from the China Securities Regulatory Commission for its proposed issuance of corporate bonds to qualified investors in the People's Republic of China (China). The notice is valid for 24 months from the date of issuance, during which China Resources Double-Crane can issue corporate bonds with a total amount of 3 billion yuan in installments.

CHINARES PHARMA (03320) announces that its non-wholly owned subsidiary China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane Pharmaceutical) has received a registration approval notice (CSRC License [2026] No. 118) from the China Securities Regulatory Commission for the proposed issuance of corporate bonds by China Resources Double-Crane Pharmaceutical to qualified investors in the People's Republic of China. The notice is valid for 24 months from the date of issuance, during which China Resources Double-Crane Pharmaceutical may issue corporate bonds in installments totaling RMB 3 billion.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!